WILLOW SPRINGS, Ill. (WGN) — There has been an extraordinary step forward in the treatment of spinal cord injuries. For the patients who come through the door of the Next Steps clinic in southwest ...

An individual may become completely paralyzed because of any number of accidents that interfere with the functioning of the ...

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulation Devices Global Market Report by Product, Application, End User, Countries and Company Analysis, 2025-2033" has been added to ...

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

Spinal cord stimulation, a medical technology suggested to treat people with chronic back pain, does not provide long-term relief and may cause harm, according to a Cochrane Review released today.

Spinal cord stimulators have been used since the 1960s, and the first FDA approval for one of the devices arrived in 1989—all with a focus on treating various forms of chronic pain. In more recent ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Avantis spinal cord stimulation system (Reach Neuro, Inc), which has been shown in early testing to restore ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Independent studies suggested that spinal cord stimulation ...

(MENAFN- GlobeNewsWire - Nasdaq) Regionally, North America leads, followed by Europe, with fast growth in Asia-Pacific. Challenges include high costs, surgery risks, and regulatory delays. Despite ...

Spinal cord stimulation, a medical technology suggested to treat people with chronic back pain, does not provide long-term relief and may cause harm, according to a Cochrane Review released today.